Results 81 to 90 of about 1,692 (164)

Early Effect of 0.005% Estriol Vaginal Gel on Symptoms and Signs of Vulvovaginal Atrophy. [PDF]

J Menopausal Med, 2022
Lázaro-Carrasco de la Fuente J, Cuerva González M, González Rodríguez S, Delgado Marín JL, Cuevas Castillo C, Nieto Magro C.   +5 more
europepmc   +1 more source

Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination

International Journal of Women's Health, 2013
Sebastian Mirkin,1 James H Pickar21Pfizer Inc, Collegeville, PA, 2Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY, USAAbstract: Loss of estrogen production in women during menopause results in a state of estrogen
Mirkin S, Pickar JH
doaj  

Comparison of topical estrogen and platelet-rich plasma injections in the treatment of postmenopausal vaginal atrophy

Frontiers in Medicine
BackgroundPlatelet-rich plasma (PRP) is considered safe and is a low-cost, simple, natural, and minimally invasive method for vaginal rejuvenation. We aimed to compare the effects of hormonal treatment options and PRP use for postmenopausal vulvovaginal ...
Ufuk Atlihan, Can Ata, Onur Yavuz, Huseyin Aytug Avsar, Selcuk Erkilinc, Tevfik Berk Bildaci   +5 more
doaj   +1 more source

An online survey on coping methods for genitourinary syndrome of menopause, including vulvovaginal atrophy, among Japanese women and their satisfaction levels. [PDF]

BMC Womens Health, 2023
Ohta H, Hatta M, Ota K, Yoshikata R, Salvatore S.   +4 more
europepmc   +1 more source

Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis. [PDF]

Menopause, 2023
Simon JA, Ferenczy A, Black D, Castonguay A, Royer C, Marouf R, Beauchemin C.   +6 more
europepmc   +1 more source

Effects of Non-Ablative Solid-State Vaginal Laser (SSVL) for the Treatment of Vulvovaginal Atrophy in Breast Cancer Survivors after Adjuvant Aromatase Inhibitor Therapy: Preliminary Results. [PDF]

J Clin Med, 2023
Lubián-López DM, Butrón-Hinojo CA, Menjón-Beltrán S, González-Mesa E, Tapiador-Albertos S, Rodríguez-Jiménez B, Fiol-Ruiz G.   +6 more
europepmc   +1 more source

Clinical Efficacy of Hormonal and Nonhormonal Agents in the Treatment of Vulvovaginal Atrophy. [PDF]

J Menopausal Med, 2021
Ilhan G, Aslan MM, Cevrioglu AS, Yıldırım M, Erkorkmaz U.   +4 more
europepmc   +1 more source

Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study. [PDF]

PLoS One, 2022
Garcia de Arriba S, Grüntkemeier L, Häuser M, May TW, Masur C, Stute P.   +5 more
europepmc   +1 more source

The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: A state-of-the-art review. [PDF]

Acta Obstet Gynecol Scand, 2022
Mortensen OE, Christensen SE, Løkkegaard E.   +2 more
europepmc   +1 more source

Vulvovaginal atrophy during menopause

, 2017
Objective: To present a basic clinical research based on current evidence about advanced treatment methods for vulvovaginal atrophy during menopause.And on principles of management of patients with vulvovaginal atrophy.Vulvovaginal atrophy (VVA) is a common and underreported condition associated with decreased estrogenization of the vaginal tissue ...
openaire   +1 more source